Moxifloxacin hydrochloride monohydrate,
UNII-B8956S8609,
192927-63-2,
Actira,
B8956S8609,
NCGC00183881-01,
DSSTox_CID_28989,
DSSTox_RID_83254,
DSSTox_GSID_49063,
SCHEMBL1402247,
CHEMBL2326947,
DTXSID1049063,
C21H24FN3O4.ClH.H2O,
Moxifloxacin Hydrochloride Hydrate,
SKZIMSDWAIZNDD-WJMOHVQJSA-N,
Tox21_113616,
2562AH,
MFCD09836237,
AKOS022183009,
API0008237,
7-((4aS,7aS)-Octahydro-1h-pyrrolo(3,4-b)pyridin-6-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrate hydrochloride,
AC-30418,
CAS-192927-63-2,
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride,
Proflox,
Avalox,
Bay-12-8039,
CID9890250,
Moxifloxacin, Hydrochloride Monohydrate,
CID 9890250,
1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride hydrate,
1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride hydrate,